UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities and Exchange Act 1934
Date of Report (Date of earliest event reported): January 8, 2010
IntegraMed America, Inc.
-------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware
-------------------------------------------------------------------------------
(State of other jurisdiction of incorporation)
0-20260 6-1150326
-------------------------------------------------------------------------------
(Commission File Numbers) (IRS Employer Identification No.)
Two Manhattanville Road, Purchase, NY 10577
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone no. including area code: (914) 253-8000
(Former name or former address, if changed since last report)
-------------------------------------------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
Written communication pursuant to Rule 425 under the Securities Act (17
__ CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
__ CFR 240.14a-12)
Pre-commencement communication pursuant to Rule 14d-2(b) under the
__ Exchange Act (17 CFR 240.14d-2(b)
Pre-commencement communication pursuant to Rule 13e-4(c) under the
__ Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01 Regulation FD Disclosure
On January 8, 2010, Registrant issued a press release, which is
attached hereto as exhibit 99.1 and incorporated herein by reference.
ITEM 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
Exhibit No. Description of Exhibit
----------- ----------------------
99.1 Registrant's Press Release dated January 8, 2010.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IntegraMed America, Inc.
(Registrant)
Date: January 8, 2010 By: /s/John W. Hlywak, Jr.
----------------------------
John W. Hlywak, Jr.
Executive Vice President and
Chief Financial Officer
(Principal Financial and
Accounting Officer)